Pancreatic Cancer is the 3rd biggest killer of all cancers (set to rise to 2nd place) and despite this, there are still no effective diagnostic tools or treatments available.

Oncoparse wants to change this by developing a next-generation diagnostic assay that will use a simple blood test to determine the Tumour DNA levels in the body allowing clinicians to make agile and informed decisions on patient treatment plans.

Oncoparse is currently growing and would like to invite interested parties - be it to invest, join us in the labs or share experiences - to reach out to Martin (martin@oncoparse.com).